CONTEXT: Malignant melanoma is the third most common cause of cerebral metastases after breast and lung cancer. Despite advances in therapeutic options, the prognosis for patients with cerebral metastases from melanoma remains poor, with a median survival time of six months after diagnosis. CASE REPORT: A 65-year-old woman was diagnosed with a malignant melanoma on the third toe of her left foot. The tumorous spot was excised surgically. However, the melanoma reappeared after one year and skin biopsy confirmed recurrence of malignant melanoma. Investigations showed metastasis to the left pelvic region, left lobe of the liver and right lobe of the lung. The patient then received chemotherapy. Subsequently, the patient was brought to the emergency department with an altered level of consciousness (Glasgow coma scale: 9) and hemiplegia on the right side of her body. Computed tomography scans of the brain revealed hemorrhagic lesions in the parieto-occipital lobes of the brain. Urgent surgical evacuation was done to remove the lesion, following which the patient showed improvement in her score on the Glasgow coma scale and a concomitant decrease in weakness. She was discharged from hospital with full consciousness. The patient died of acute renal failure 14 months after the brain surgery and approximately 4 years after the initial presentation of the case. CONCLUSION: This case outcome is rare and shows the effectiveness of surgery to treat cerebral metastasis from malignant melanoma in a situation with multisystem metastasis already present.
INTRODUCTION
Melanoma, the cancer of melanocytes, i.e. the pigment-forming cells of the body, is the least common but most lethal of all skin cancers. 1 The onset of the disease is marked by uncontrolled division of melanocytes between the epidermis and dermis, which is followed by radial invasive growth and vertical growth phases, respectively. 2 The main causative agent of melanoma is exposure to ultraviolet (UV) radiation, particularly UV-B.
Treatment of melanoma is palliative in nature. A clinical diagnosis is required, followed by wide-margin excision of the tumor. Excisional biopsies may remove the tumor, but further surgery is often necessary to reduce the risk of recurrence. Complete surgical excision with adequate surgical margins and assessment for the presence of detectable metastatic disease, along with short and long-term follow-up, is the standard treatment protocol. 2 Several treatment regimens including interferon therapy improve the prognosis but have severe side effects.
CASE REPORT
The patient was a 65-year-old woman who developed a dark skin lesion on the third toe of her left A CT scan of the chest was performed in June 2015, and this revealed two well-defined hypodense pulmonary lesions of 8 × 7 mm and 7 × 6 mm, respectively, which were indicative of secondary metastasis. However, there was a reduction in the size of the primary lung lesion that had been observed prior to chemotherapy. Nonetheless, the chemotherapeutic regimen was continued for another three months with a reduced dose.
On July 22, 2015, the patient suddenly complained of altered consciousness and hemiplegia on the right side of her body, with a score of 9 on the Glasgow coma scale (GCS). A CT scan revealed an intracerebral hemorrhagic mass, which was treated with urgent resection by means of parieto-occipital loop-assisted craniotomy on the same day ( Figure 1A-C) . Histopathological 
June
New chest CT scan shows a reduction in the size of the primary lung lesion that had been observed prior to chemotherapy.
July 22
Sudden right-side weakness and disturbed consciousness, leading to urgent surgical evacuation by means of loop-assisted parietooccipital craniotomy.
2015 August 1 Discharge with GCS 15, with improvement in weakness.
2016 September 16 Death due to renal failure.
CT = computed tomography; GCS = Glasgow coma scale.
and cytological reports on the intracranial hematoma showed positivity for melan A and HMB-45. The patient was discharged after the surgery, on August 1, 2015, with improved consciousness (GCS 15).
Unfortunately, she died from renal failure on September 16, 2016, 14 months after the brain surgery and approximately 4 years after the first presentation of this case. This is a rare and unprecedented case among the among known occurrences of metastatic melanoma that were already multisystemic ( Table 1) .
DISCUSSION
Several imaging techniques such as X-ray, ultrasonography, magnetic resonance imaging (MRI), CT scan and positron emission tomography (PET) scan are regularly used to detect metastatic melanomas. 3, 4 In the present case, combinations of all these methods were successfully used to evaluate the patient's condition.
Here, we found that the patient presented a partial response to chemotherapy consisting of three drugs with anti-mitogenic effects.
Despite complete remission in the case of the hepatic lesion and partial regression of the primary pulmonary lesion, the melanoma rapidly metastasized to the brain, thus indicating a requirement for invasive interventional methods.
Radiation therapy is another palliative method of choice that has been shown to extend life span by 3-5 months. It is often combined with systemic treatments such as use of immunotherapeutic drugs, to improve the prognosis of cerebral metastasis from melanoma. 5, 6 However, the precise location of the metastasis inside the brain (intra or extracranial) is a decisive factor for the extent to which the treatment can be used successfully with minimal side effects. Considering the drawbacks of the existing strategies, the search for better alternatives for treating brain metastasis from melanoma is still on ( Table 2) .
Here, we found that intracranial surgery significantly improved the clinical symptoms associated with brain metastasis from melanoma in our patient. The prognosis for brain metastasis from melanoma is poor, with a median survival span of 2-10 months.
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CONCLUSIONS
This is the first report highlighting success from intracranial surgery to alleviate the symptoms of a patient with brain metastasis from melanoma that had progressed with systemic dissemination for a considerable length of time. This case is unprecedented in the history of prognoses from multisystemic metastatic melanoma. The outcome from this case is rare and shows the effectiveness of surgery in improving the prognosis and treating brain melanoma that already has systemic metastasis. Total number of articles retrieved from PubMed, removing duplications, was 5.
